Open AccessMetronomic Docetaxel in PRINT Nanoparticles and EZH2 Silencing Have Synergistic Antitumor Effect in Ovarian Cancer
Author(s) -
K. M. Gharpure,
K. S. Chu,
C. J. Bowerman,
T. Miyake,
S. Pradeep,
S. L. Mangala,
H.-D. Han,
R. Rupaimoole,
G. N. Armaiz-Pena,
T. B. Rahhal,
S. Y. Wu,
J. C. Luft,
M. E. Napier,
G. Lopez-Berestein,
J. M. DeSimone,
A. K. Sood
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/zkyq-v482
Subject(s) - docetaxel , gene silencing , ovarian cancer , ezh2 , cancer , cancer research , oncology , medicine , chemistry , epigenetics , gene , biochemistry